- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2010
- Public Summary Document (PSD) March 2010 PBAC Meeting - PDF
Salbutamol sulfate – March 2010
Salbutamol Sulfate, oral pressurised inhalation, 100 micrograms (base) per dose (200 doses), CFC-free formulation with spacer, VentSpacer®
Last updated
16 July 2010